Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150461
Full metadata record
DC FieldValueLanguage
dc.creatorMatos, R
dc.creatorFonseca, KL
dc.creatorMereiter, S
dc.creatorMaceiras, AR
dc.creatorGomes, J
dc.creatorVilaplana, C
dc.creatorGärtner, F
dc.creatorRodrigues, P
dc.creatorReis, CA
dc.creatorSaraiva, M
dc.creatorMagalhães, A
dc.date.accessioned2023-06-27T13:24:38Z-
dc.date.available2023-06-27T13:24:38Z-
dc.date.issued2021
dc.identifier.issn2076-2607
dc.identifier.urihttps://hdl.handle.net/10216/150461-
dc.description.abstractGlycans display increasingly recognized roles in pathological contexts, however, their impact in the host-pathogen interplay in many infectious diseases remains largely unknown. This is the case for tuberculosis (TB), one of the ten most fatal diseases worldwide, caused by infection of the bacteria Mycobacterium tuberculosis. We have recently reported that perturbing the core-2 O-glycans biosynthetic pathway increases the host susceptibility to M. tuberculosis infection, by disrupting the neutrophil homeostasis and enhancing lung pathology. In the present study, we show an increased expression of the sialylated glycan structure Sialyl-Lewis X (SLeX) in the lung epithelium upon M. tuberculosis infection. This increase in SLeX glycan epitope is accompanied by an altered lung tissue transcriptomic signature, with up-regulation of genes codifying enzymes that are involved in the SLeX core-2 O-glycans biosynthetic pathway. This study provides novel insights into previously unappreciated molecular mechanisms involving glycosylation, which modulate the host response to M. tuberculosis infection, possibly contributing to shape TB disease outcome.
dc.description.sponsorshipThis work was financed by FEDER—Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT—Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Inovação in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274) and by grants POCI-01-0145-FEDER-028955 (to MS), POCI-01-0145-FEDER-028489 (to AM), and POCI-01-0145-FEDER-016585 (to CAR). CAR acknowledges the Consortium for Functional Glycomics funded by NIGMS-GM62116. This study was funded by the Spanish Government-FEDER Funds through CP13/00174, CPII18/00031 and PI16/01511 grants, and the CIBER Enfermedades Respiratorias Network; and by the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) through grant 16/023. KLF and RM are funded by FCT PhD scholarships SFRH/BD/114405/2016 and SFRH/BD/131159/2017, respectively; MS is funded by FCT through Estímulo Individual ao Emprego Científico. The APC was funded by FCT (POCI-01-0145-FEDER-028489).
dc.language.isoeng
dc.publisherMDPI
dc.relationinfo:eu-repo/grantAgreement/FCT/OE/SFRH%2FBD%2F114405%2F2016/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F131159%2F2017/PT
dc.relation.ispartofMicroorganisms, vol.9:99
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleMycobacterium tuberculosis infection up-regulates sialyl lewis x expression in the lung epithelium
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/microorganisms9010099
dc.relation.publisherversionhttps://www.mdpi.com/2076-2607/9/1/99
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-microorganisms9010099.pdf2.61 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons